Type 2 Diabetes Treatment - Part 6 - SGLT2 Inhibitors

September 26th, 2018

Sodium-Glucose Transporter 2 Inhibitors decrease glucose re-absorbtion. The diuretic effect, weight loss, DKA, cardiac outcomes, blood pressure, genital infections and a whole bunch of other information is discussed.

SGLT2s include Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance), Ertagliflozin (Steglatro), with more to be released in the future.

Share | Download(Loading)
Podbean App

Play this podcast on Podbean App